Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ZWH
|
||||
Former ID |
DNC001486
|
||||
Drug Name |
UK-279,276
|
||||
Indication | Stroke [ICD9: 434.91, 437.6, 453, 671.5, 671.9; ICD10:I61-I63, I80-I82] | Discontinued in Phase 2 | [545570] | ||
Company |
Corvas
|
||||
CAS Number |
CAS 166518-60-1
|
||||
Target and Pathway | |||||
Target(s) | Integrin beta-2 | Target Info | Antagonist | [536373] | |
KEGG Pathway | Rap1 signaling pathway | ||||
Phagosome | |||||
Hippo signaling pathway | |||||
Cell adhesion molecules (CAMs) | |||||
Natural killer cell mediated cytotoxicity | |||||
Leukocyte transendothelial migration | |||||
Regulation of actin cytoskeleton | |||||
Pertussis | |||||
Legionellosis | |||||
Leishmaniasis | |||||
Malaria | |||||
Amoebiasis | |||||
Staphylococcus aureus infection | |||||
Tuberculosis | |||||
HTLV-I infection | |||||
Rheumatoid arthritis | |||||
Viral myocarditis | |||||
PANTHER Pathway | Integrin signalling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.